Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2559
Source ID: NCT00879710
Associated Drug: Simvastatin Or Ezetimibe
Title: Effect of Diabetes Mellitus on Cholesterol Metabolism
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT00879710/results
Conditions: Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus|Hypercholesterolemia
Interventions: DRUG: simvastatin or ezetimibe
Outcome Measures: Primary: Changes in LDL Cholesterol, Subjects with T1DM or T2DM were assigned to alternating therapy with simvastatin (40 mg) or ezetimibe (10 mg) for 6 weeks in a crossover design. The data are reported as follows. Subjects with type 1 diabetes mellitus: Simvastatin: Changes in LDL after 6-week therapy with simvastatin (irrespective of the treatment order) Ezetimibe: Changes in LDL after 6-week therapy with ezetimibe (irrespective of the treatment order) Subjects with type 2 diabetes mellitus: Simvastatin: Changes in LDL after 6-week therapy with simvastatin (irrespective of the treatment order) Ezetimibe: Changes in LDL after 6-week therapy with ezetimibe (irrespective of the treatment order), 6 weeks after starting drug therapy | Secondary: Changes in Cholesterol Absorption or Synthesis Rates From the Baseline, Our plan was to measure changes in cholesterol absorption and synthesis rates from the baseline after 6 weeks of statin or ezetimibe therapy., 6 weeks after initiation of drug therapy
Sponsor/Collaborators: Sponsor: Medical College of Wisconsin
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 57
Study Type: INTERVENTIONAL
Study Designs: Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2008-08
Completion Date: 2013-07
Results First Posted: 2016-04-18
Last Update Posted: 2020-07-29
Locations: Medical College of Wisconsin /Froedtert Hospital, Milwaukee, Wisconsin, 53226, United States
URL: https://clinicaltrials.gov/show/NCT00879710